Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Awakn Life Sciences Corp (AWKN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.14 -0.03    -17.14%
03/05 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 500
  • Bid/Ask: 0.14 / 0.17
  • Day's Range: 0.14 - 0.14
Type:  Equity
Market:  Canada
Awakn Life Sciences 0.14 -0.03 -17.14%

Awakn Life Sciences Corp Company Profile

 
Get an in-depth profile of Awakn Life Sciences Corp, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

44

Equity Type

ORD

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

Contact Information

Address 301-217 Queen Street West
Toronto, M5V 0R2
Canada
Phone -
Fax -

Top Executives

Name Age Since Title
Anthony Tennyson - 2020 Co-founder, President, CEO & Director
George Scorsis 46 2020 Co-founder & Chairman of the Board
Stephen Page - 2021 Independent Non Executive Director
Kevin Fone - 2021 Member of Pre-Clinical Advisory Board
Barbara J. Mason - 2021 Member of Clinical Advisory Board
Shaun McNulty - 2021 Member of Pre-Clinical Advisory Board
Stephen Husbands - 2021 Member of Pre-Clinical Advisory Board
Harriet de Wit - 2021 Member of Pre-Clinical Advisory Board
David John Nutt - 2021 Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer
Ann Mithoefer - 2020 Member of Clinical Advisory Board
Paul Rutherford Carter 63 2021 Independent Director
John Papastergiou - 2021 Independent Non Executive Director
Michael Mithoefer - - Member of Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AWKN Comments

Write your thoughts about Awakn Life Sciences Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email